Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Addex Therapeutics Ltd
  6. News
  7. Summary
    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD

(ADXN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Addex Therapeutics : Enrolls First Patient in Mid-Stage Study of Epilepsy Drug

06/07/2021 | 03:33am EDT


ę MT Newswires 2021
All news about ADDEX THERAPEUTICS LTD
08/02ADDEX THERAPEUTICS : Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev..
PU
08/02ADDEX THERAPEUTICS : to Release Half-Year 2021 Financial Results and Host Confer..
AQ
08/02PRESS RELEASE : Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kaliniche..
DJ
08/02Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head of ..
DJ
08/02PRESS RELEASE : Addex Therapeutics to Release Half-Year 2021 Financial Results a..
DJ
08/02Addex Therapeutics Ltd Appoints Mikhail Kalinichev as Head of Translational S..
CI
07/29ADDEX THERAPEUTICS : and Indivior Extend Research Collaboration on GABAB Positiv..
PU
07/29PRESS RELEASE : Addex and Indivior Extend Research Collaboration on GABAB Positi..
DJ
07/29ADDEX THERAPEUTICS : and Indivior Extend Research Collaboration on GABAB Positiv..
AQ
07/29Addex Therapeutics and Indivior Extend Research Collaboration on Gabab Positi..
CI
More news
Financials
Sales 2021 1,61 M 1,78 M 1,78 M
Net income 2021 -15,1 M -16,7 M -16,7 M
Net Debt 2021 5,28 M 5,84 M 5,84 M
P/E ratio 2021 -3,55x
Yield 2021 -
Capitalization 66,5 M 73,5 M 73,6 M
EV / Sales 2021 44,6x
EV / Sales 2022 98,8x
Nbr of Employees 27
Free-Float 80,5%
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADDEX THERAPEUTICS LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 1,53 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Timothy Dyer Chief Executive Officer & Director
LÚnaic TeyssÚdou Head-Finance
Vincent M. Lawton Chairman
Roger G. Mills Director & Chief Medical Officer
Raymond George Hill Director
Sector and Competitors
1st jan.Capi. (M$)
ADDEX THERAPEUTICS LTD-25.38%74
MODERNA, INC.231.78%139 174
LONZA GROUP AG25.60%58 688
IQVIA HOLDINGS INC.38.03%47 386
CELLTRION, INC.-26.60%31 285
SEAGEN INC.-11.93%28 062